PA
DVAX

Perceptive Advisors’s Dynavax Technologies DVAX Stock Holding History

Perceptive Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,600
Closed -$5K – 176
2016
Q4 		$5K Buy
+15,600
New +$114K ﹤0.01% 171

Other funds holding DVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors's DVAX Position: Q3 2020 in Review

Perceptive Advisors sold out of Dynavax Technologies (DVAX) in Q3 2020, closing a stake of 176,950 shares — an estimated $1.57M sold.

Perceptive Advisors first reported a position in DVAX in Q2 2016 and held it in 3 quarters. The position peaked at $1.57M in Q2 2020. 165 funds tracked by Wall St. Rank hold DVAX as of Q3 2020.

  • Perceptive Advisors reported no remaining Dynavax Technologies position as of Q3 2020 after selling out during the quarter.
  • Perceptive Advisors sold 176,950 Dynavax Technologies shares in Q3 2020, an estimated $1.57M.
  • Perceptive Advisors first reported a position in Dynavax Technologies in Q2 2016 and held it in 3 quarters.
  • Perceptive Advisors's Dynavax Technologies position peaked at $1.57M in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2020.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.